MMJ's innovative soft gelatin THC-CBD capsule, known as MMJ-002, is undergoing the rigorous FDA approval process to validate ...

In this digital era, Vamsi Upputuri, a leading expert in regulatory automation, explores cutting-edge advancements in ...

President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive ...

Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell ...

USAID's stop-work order threatens to undo decades of progress in medical research ethics and cause harm to clinical trial ...

FYB202 is an interleukin inhibitor that can be used in dermatology to treat psoriasis and in gastroenterology to treat chronic inflammatory bowel disease. The biosimilar received marketing ...

Zheng discusses the differences in rules and regulations across the world in clinical trials, looking at areas such as patient recruitment and clinical research. The past decades have witnessed ...

Yet, some use cases can be more easily applied to almost every clinical trial organisation ... as data privacy regulations surrounding patients’ medical data are exceptionally stringent.

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference ...

Planegg-Martinsried, Germany - Formycon AG (FSE: FYB, Prime Standard) (“Formycon” or “the Company”) today provided an update on key developments across various biosimilar projects and invites ...